Vericiguat for worsening heart failure
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if adding vericiguat to standard heart failure medicines helps people hospitalized with worsening heart failure. It's for those with a weak heart pump and high NT-proBNP levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure that is getting worse (symptoms like shortness of breath, swelling)
- Your heart's pumping ability is less than or equal to 45%
- You have a high NT-proBNP level (a marker of heart strain)
- Your blood pressure is at least 100 mmHg
- You are not currently using long-acting nitrates, other similar heart medicines, or intravenous inotropes
- You do not have a left ventricular assist device (heart pump)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the drug vericiguat helps people with heart failure after a heart attack. The trial looks at people whose heart pumping is weak and who have symptoms despite standard treatment.
This study tests whether adding a new medicine called vericiguat to standard heart failure treatments helps patients with heart failure feel better and avoid hospital stays. Vericiguat is a pill that may improve heart function and reduce symptoms like shortness of breath and fatigue.
This trial tests how a medication called vericiguat works in people with both chronic kidney disease and heart failure. It aims to see if the drug helps manage these conditions together.
This study tests a medicine called vericiguat (a pill) to see if it can improve the heart's shape and function in people with heart failure and a weakened pump. You would keep taking your usual heart medications plus the study drug.
This study tests a drug called vericiguat, which may help people with heart failure and a leaky tricuspid valve. It aims to improve heart function and reduce symptoms.
This trial tests whether adding vericiguat to your usual heart failure medicines helps reduce pressure in your lungs and improve symptoms. You will have a CardioMEMS sensor already implanted to monitor your heart, and the study will use its readings to guide your care.
Hear when a new Decompensated Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.